Tetrahydropyran compounds as tachykinin antagonists

Details for Australian Patent Application No. 2004218228 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Dirat, Olivier; Elliott, Jason Matthew; Huscroft, Ian Thomas; Jelley, Richard Alexander; Kulagowski, Janusz Jozef; Raubo, Piotr Antoni; Shaw, Duncan Edward; Sternfeld, Francine; Swain, Christopher John

Agent Spruson & Ferguson

Pub. Number AU-A-2004218228

PCT Pub. Number WO2004/078750

Priority 0305280.0 07.03.03 GB; 0305282.6 07.03.03 GB; 0305823.7 13.03.03 GB; 0305822.9 13.03.03 GB; 0305279.2 07.03.03 GB; 0305283.4 07.03.03 GB; 0305281.8 07.03.03 GB

Filing date 4 March 2004

Wipo publication date 16 September 2004

International Classifications

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/10 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 031/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 025/00 Drugs for disorders of the nervous system

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 307/00 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 205/00 Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/078750 Priority application(s): WO2004/078750

20 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218239-5-phenylthiazole derivatives and their use as P13 kinase inhibitors

2004218224-Support/assembly structure and article retaining arrangements